CfdnaExtractionYieldChecker

Cfdna Extraction Yield

Liquid Biopsy жидкостная биопсия cfDNA ctDNA CTC exosomes NGS qPCR
Open selection

Utility description: Cfdna Extraction Yield

Cfdna Extraction Yield Checker — cfDNA Extraction Quality Control

ℹ️  Utility performs comprehensive assessment of circulating free DNA extraction quality according to CAP/CLIA standards for liquid biopsy:
     • Material Yield: Verification of total cfDNA amount and concentration against minimum NGS thresholds.
     • Efficiency Control: Assessment of exogenous spike-in recovery to exclude technical extraction errors.
     • Sample Purity: Control of high molecular weight genomic DNA (HMW gDNA) level masking ctDNA signal.
     • Fragmentation: Verification of characteristic nucleosomal peak (~167 bp) as true cfDNA marker.

⚠️  IMPORTANT: 
     • Low cfDNA yield (<5-10 ng) makes reliable detection of mutations with VAF <0.5% impossible.
     • gDNA contamination >10% significantly reduces signal-to-noise ratio in sequencing.

Usage:
  CfdnaExtractionYieldChecker.exe                            → demo mode (console output)
  CfdnaExtractionYieldChecker.exe input.csv output.json      → evaluate your data

Input format:
SampleID,ExtractionKit,InputPlasmaVolume_mL,ElutionVolume_uL,Concentration_ng_uL,MinConcentration_ng_uL,TotalYield_ng,MinTotalYield_ng,SpikeIn_Recovery_Percent,MinSpikeIn_Recovery_Percent,HMW_gDNA_Percent,MaxHMW_gDNA_Percent,FragmentSize_Peak_bp

Example:
  CFDNA-001,QIAamp,2.0,50,0.8,0.2,40.0,5.0,85.0,50.0,3.5,10.0,167

📍 Scope of Application (Usage Where):
     • Liquid Biopsy Laboratories: Incoming control before NGS library construction.
     • Oncology Research: Ensuring sufficient material for rare variant detection.
     • Non-Invasive Prenatal Testing (NIPT): Fetal DNA quality control.
     • Method Development: Comparison of different extraction kit efficiencies.

— WHY IS THIS NEEDED?
cfDNA amount in plasma is limited and varies between patients.
Without strict yield and purity control, analytical test sensitivity cannot be guaranteed.
Automated verification prevents launching expensive sequencing on substandard material.

⚠️  CRITICAL:
• Spike-In Recovery: Low recovery (<50%) indicates DNA loss on column/magnetic beads.
• HMW gDNA: High level indicates double centrifugation protocol violation.
• Fragment Peak: Shift from 167 bp may indicate degradation or preparation artifacts.
• Input Volume: Insufficient plasma volume (<1-2 mL) is frequent cause of low yield.

Key features:
• Five-parameter extraction quality assessment
• Status differentiation (Pass/Low Yield Warning/Fail)
• Support for various commercial kits
• Structured QC report generation
• Compliance with CAP Molecular Pathology Checklist requirements

Critical parameters:
• Total Yield: ≥ Min Limit (typically 5-10 ng)
• Concentration: ≥ Min Limit (typically 0.2 ng/µL)
• Spike-In Recovery: ≥ 50%
• HMW gDNA: ≤ 10%
• Fragment Peak: 150-180 bp

💡 Usage tips:
1. Double Centrifugation: Mandatory for cell removal and gDNA reduction.
2. Plasma Freshness: Process blood within 2-4 hours or use stabilization tubes.
3. Spike-In: Add internal control before extraction start to monitor entire process.
4. Measurement: Use high-sensitivity methods (Qubit dsDNA HS, TapeStation) instead of NanoDrop.
5. Re-extraction: Upon low yield, consider re-extraction from remaining plasma.

⚠️ Note: This utility is a pre-analytical stage control tool. It does not replace bioinformatics analysis but guarantees that input data meets sensitivity requirements.

input.csv

SampleID,ExtractionKit,InputPlasmaVolume_mL,ElutionVolume_uL,Concentration_ng_uL,MinConcentration_ng_uL,TotalYield_ng,MinTotalYield_ng,SpikeIn_Recovery_Percent,MinSpikeIn_Recovery_Percent,HMW_gDNA_Percent,MaxHMW_gDNA_Percent,FragmentSize_Peak_bp
CFDNA-2026-001,QIAamp Circulating Nucleic Acid,2.0,50,0.8,0.2,40.0,5.0,85.0,50.0,3.5,10.0,167
CFDNA-2026-002,MagMAX Cell-Free DNA,1.0,30,0.1,0.2,3.0,5.0,40.0,50.0,25.0,10.0,165
CFDNA-2026-003,QIAamp Circulating Nucleic Acid,2.0,50,1.2,0.2,60.0,5.0,92.0,50.0,2.0,10.0,168

URS & FS — User Requirements and Functional Specification

This document describes the controlled interface and behaviour of CfdnaExtractionYieldChecker for Cfdna Extraction Yield Checker.

Domain limits and critical parameters

Key fragments from the source description are shown below. Before production use, limits must be verified against the approved specification, registration dossier and local SOPs.
  • • Sample Purity: Control of high molecular weight genomic DNA (HMW gDNA) level masking ctDNA signal.
  • • Low cfDNA yield (<5-10 ng) makes reliable detection of mutations with VAF <0.5% impossible.
  • • gDNA contamination >10% significantly reduces signal-to-noise ratio in sequencing.
  • • Method Development: Comparison of different extraction kit efficiencies.
  • cfDNA amount in plasma is limited and varies between patients.
  • Without strict yield and purity control, analytical test sensitivity cannot be guaranteed.
  • ⚠️ CRITICAL:
  • • Spike-In Recovery: Low recovery (<50%) indicates DNA loss on column/magnetic beads.
  • • Input Volume: Insufficient plasma volume (<1-2 mL) is frequent cause of low yield.
  • Critical parameters:
  • • Total Yield: ≥ Min Limit (typically 5-10 ng)
  • • Concentration: ≥ Min Limit (typically 0.2 ng/µL)
  • • Spike-In Recovery: ≥ 50%
  • • HMW gDNA: ≤ 10%

URS — User Requirements Specification

IDRequirementCriticalityAcceptance criterion
URS-001The utility shall accept an input.csv file for Cfdna Extraction Yield Checker with headers defined in the data contract.HighThe file is processed without manual header editing.
URS-002The utility shall perform deterministic QC evaluation without machine learning and without probabilistic conformance decisions.HighIdentical input data, rule version and configuration produce reproducible results.
URS-003The utility shall validate mandatory fields, data types, ranges, units and domain plausibility.HighSchema, conversion and range errors are explicitly reported.
URS-004The utility shall apply domain limits and rules from the description, approved specification, registration dossier and local SOPs.HighEach check has PASS/WARNING/FAIL and a clear message.
URS-005The utility shall generate output.json with machine-readable results, source values, warnings, failures and critical findings.HighJSON is suitable for LIMS/ELN/MES integration and QA/QC review.
URS-006The utility shall preserve traceability between batch/sample, input file, applied rules and final status.HighOutput contains identifiers, checked parameters and audit metadata.
URS-007The documentation shall support IQ/OQ/PQ, CSV/CSA and review by internal QA or inspectors.MediumURS, FS, input/output contract and test scenarios are supplied with the utility.
URS-008The utility shall be used as a QC decision-support tool and not as a substitute for approved specifications and QA/QP release decision.MediumDocumentation states change control and limit-verification expectations.

input.csv contract

#FieldTypeSamplePurpose
1SampleIDstring / controlled vocabularyCFDNA-2026-001Sample or laboratory specimen identifier.
2ExtractionKitstring / controlled vocabularyQIAamp Circulating Nucleic AcidControlled input parameter for deterministic QC rules.
3InputPlasmaVolume_mLdecimal2.0Volume/dose used for load, limit or release calculation.
4ElutionVolume_uLdecimal50Volume/dose used for load, limit or release calculation.
5Concentration_ng_uLdecimal0.8Component ratio; structural or formulation CQA.
6MinConcentration_ng_uLdecimal0.2Component ratio; structural or formulation CQA.
7TotalYield_ngdecimal40.0Controlled input parameter for deterministic QC rules.
8MinTotalYield_ngdecimal5.0Controlled input parameter for deterministic QC rules.
9SpikeIn_Recovery_Percentdecimal85.0Recovery; indicator of analytical validity.
10MinSpikeIn_Recovery_Percentdecimal50.0Recovery; indicator of analytical validity.
11HMW_gDNA_Percentdecimal3.5Biological/molecular component controlled as a CQA.
12MaxHMW_gDNA_Percentdecimal10.0Biological/molecular component controlled as a CQA.
13FragmentSize_Peak_bpdecimal167Controlled input parameter for deterministic QC rules.
SampleID,ExtractionKit,InputPlasmaVolume_mL,ElutionVolume_uL,Concentration_ng_uL,MinConcentration_ng_uL,TotalYield_ng,MinTotalYield_ng,SpikeIn_Recovery_Percent,MinSpikeIn_Recovery_Percent,HMW_gDNA_Percent,MaxHMW_gDNA_Percent,FragmentSize_Peak_bp
CFDNA-2026-001,QIAamp Circulating Nucleic Acid,2.0,50,0.8,0.2,40.0,5.0,85.0,50.0,3.5,10.0,167
CFDNA-2026-002,MagMAX Cell-Free DNA,1.0,30,0.1,0.2,3.0,5.0,40.0,50.0,25.0,10.0,165
CFDNA-2026-003,QIAamp Circulating Nucleic Acid,2.0,50,1.2,0.2,60.0,5.0,92.0,50.0,2.0,10.0,168

Input validation rules

IDFieldRuleCriticality
VR-001SampleIDThe field shall match an approved dictionary or accepted string representation.High
VR-002ExtractionKitThe field shall match an approved dictionary or accepted string representation.High
VR-003InputPlasmaVolume_mLThe field shall match an approved dictionary or accepted string representation.High
VR-004ElutionVolume_uLThe field shall match an approved dictionary or accepted string representation.Medium
VR-005Concentration_ng_uLThe field shall match an approved dictionary or accepted string representation.Medium
VR-006MinConcentration_ng_uLThe field shall match an approved dictionary or accepted string representation.Medium
VR-007TotalYield_ngThe field shall match an approved dictionary or accepted string representation.Medium
VR-008MinTotalYield_ngThe field shall match an approved dictionary or accepted string representation.Medium
VR-009SpikeIn_Recovery_PercentThe field shall match an approved dictionary or accepted string representation.Medium
VR-010MinSpikeIn_Recovery_PercentThe field shall match an approved dictionary or accepted string representation.Medium
VR-011HMW_gDNA_PercentThe field shall match an approved dictionary or accepted string representation.Medium
VR-012MaxHMW_gDNA_PercentThe field shall match an approved dictionary or accepted string representation.Medium
VR-013FragmentSize_Peak_bpThe field shall match an approved dictionary or accepted string representation.Medium

FS — Functional Specification

IDFunctionImplementation
FS-001CLI executionSupport execution modes: demo mode without arguments and production mode input.csv output.json.
FS-002CSV importRead input.csv in UTF-8/CSV-compatible format and validate header and expected columns.
FS-003Schema validationCheck mandatory fields, column count, unknown key fields and empty mandatory values.
FS-004Type conversionConvert numeric, flag and text values; invalid format is recorded as a row-level error.
FS-005Domain rule engineApply rules for Cfdna Extraction Yield Checker, including critical limits from the description and approved specification.
FS-006Status aggregationProduce final status: FAIL for critical failure, WARNING for non-critical deviation, PASS for conformance.
FS-007JSON exportWrite output.json with detailed checks, source values, warnings, failures and critical findings.
FS-008Audit supportKeep result structure suitable for review, deviation investigation and calculation reproduction.
FS-009Integration contractSupport the scenario LIMS/ELN/MES → input.csv → utility → output.json → portal/admin review.
FS-010Error handlingReturn explicit messages for missing file, empty CSV, invalid schema, output write failure and invalid format.

Example output.json

{
  "utilityId": "cfdnaextractionyieldchecker",
  "utilityFolder": "CfdnaExtractionYieldChecker",
  "package": "LiquidBiopsy",
  "overallStatus": "PASS|WARNING|FAIL",
  "sourceFile": "input.csv",
  "processedAtUtc": "2026-06-10T00:00:00Z",
  "checks": [
    {
      "parameter": "SampleID",
      "value": "CFDNA-2026-001",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-001"
    },
    {
      "parameter": "ExtractionKit",
      "value": "QIAamp Circulating Nucleic Acid",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-002"
    },
    {
      "parameter": "InputPlasmaVolume_mL",
      "value": "2.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-003"
    },
    {
      "parameter": "ElutionVolume_uL",
      "value": "50",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-004"
    },
    {
      "parameter": "Concentration_ng_uL",
      "value": "0.8",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-005"
    },
    {
      "parameter": "MinConcentration_ng_uL",
      "value": "0.2",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-006"
    },
    {
      "parameter": "TotalYield_ng",
      "value": "40.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-007"
    },
    {
      "parameter": "MinTotalYield_ng",
      "value": "5.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-008"
    },
    {
      "parameter": "SpikeIn_Recovery_Percent",
      "value": "85.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-009"
    },
    {
      "parameter": "MinSpikeIn_Recovery_Percent",
      "value": "50.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-010"
    },
    {
      "parameter": "HMW_gDNA_Percent",
      "value": "3.5",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-011"
    },
    {
      "parameter": "MaxHMW_gDNA_Percent",
      "value": "10.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-012"
    }
  ],
  "criticalFindings": [],
  "warnings": [],
  "audit": {
    "inputHash": "sha256:<calculated at runtime>",
    "rulesVersion": "<utility executable version>",
    "documentation": "CfdnaExtractionYieldChecker.documentation.html"
  }
}

Traceability matrix

URSFSTestEvidence
URS-001FS-001, FS-002OQ-001Verify execution and import of valid input.csv.
URS-002FS-005, FS-006OQ-004Repeat the same dataset and compare output.json.
URS-003FS-003, FS-004, FS-010OQ-002, OQ-003Verify missing columns and invalid types.
URS-004FS-005, FS-006OQ-004, PQ-001Verify critical deviations on real/boundary data.
URS-005FS-007, FS-009OQ-005Verify JSON schema and downstream-system suitability.
URS-006FS-008OQ-006Verify identifiers and audit metadata.
URS-007FS-008, FS-010IQ-001, OQ-007Verify documentation completeness and control evidence.
URS-008FS-005, FS-008PQ-002Verify review workflow and no replacement of QA decision.

IQ/OQ/PQ test scenarios

IDScenarioExpected result
IQ-001Verify executable, input.csv, documentation and checksum availability.Delivery set is complete; version is recorded.
OQ-001Valid sample row from input.csv.PASS or acceptable WARNING according to rules.
OQ-002Remove a mandatory CSV column.Schema error or FAIL with missing-column reference.
OQ-003Place a non-numeric value into a numeric field.Type-conversion error with row/field reference.
OQ-004Set a critical parameter outside the limit.FAIL and critical finding.
OQ-005Verify output.json structure.All mandatory sections are present and JSON is valid.
OQ-006Verify batch/sample traceability.Input and result identifiers match.
PQ-001Verify 3–5 real user batches/samples.Result is confirmed by QC/QA review.
PQ-002Verify deviation workflow and manual QA decision.Utility supports review but does not replace approved decision.

QA/QC and change control

  • Do not rename columns without updating validator, documentation and test set.
  • Retain input.csv, output.json, executable version and checksum.
  • Before production use, perform IQ/OQ/PQ or equivalent CSV/CSA verification.
  • Critical limits shall be verified against the approved specification, registration dossier and local SOPs.
  • The utility provides structured QC decision support; final release decision remains with QA/QP and approved procedures.

Included in packages

Liquid Biopsy QC Suite

QC and pre-analytical control package for liquid biopsy workflows: cfDNA/ctDNA, CTC, EV/exosomes, methylation, NGS/qPCR/ddPCR, sample quality, contamination, sensitivity and reporting checks.

Open